PAUL A FRIEDMAN Insider Trading $DARE Dare Bioscience, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL A FRIEDMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL A FRIEDMAN. PAUL A FRIEDMAN is Chief Executive Officer in INCYTE CORP ($INCY) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Cerulean Pharma Inc. ($CERU) and Director in Verastem, Inc. ($VSTM) and Director in Prelude Therapeutics Inc ($PRLD).
PAUL A FRIEDMAN in Dare Bioscience, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 18,819 shares
Current Value: $21,830
Latest Transaction: Apr 05 2017
$DARE Market Capitalization: $36.49M
$DARE Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL A FRIEDMAN in Dare Bioscience, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, DARE, INCY, SNTA, PRLD, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2017 | CERU | Cerulean Pharma In ... | FRIEDMAN PAUL A | Director | Grant | A | 0.73 | 10,273 | 7,499 | 18,819 | 8.5 K to 18.8 K (+120.21 %) |
| Jan 05 2017 | CERU | Cerulean Pharma In ... | FRIEDMAN PAUL A | Director | Grant | A | 0.77 | 4,870 | 3,750 | 8,546 | 3.7 K to 8.5 K (+132.48 %) |
| Oct 20 2016 | CERU | Cerulean Pharma In ... | FRIEDMAN PAUL A | Director | Grant | A | 1.02 | 3,676 | 3,750 | 3,676 | 0 to 3.7 K |
| Jun 24 2016 | CERU | Cerulean Pharma In ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 2.08 | 20,000 | 41,600 | 20,000 | |
| Jun 30 2015 | CERU | Cerulean Pharma In ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 4.78 | 11,000 | 52,580 | 11,000 | |
| Jun 30 2015 | CERU | Cerulean Pharma In ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 4.78 | 8,214 | 39,263 | 8,214 |
Page: 1